Study of the sentinel node in endometrial cancer at early stages: Preliminary results;Estudio del ganglio centinela en el cáncer de endometrio en estadios iniciales: Resultados preliminares

Revista Espanola de Medicina Nuclear e Imagen Molecular

Volumn 31, Issue 5, 2012, Pages 243-248

  Cordero Garcia J M ^a   Lopez de la Manzanara Cano C A ^a   Garcia Vicente A M ^a   Garrido Esteban, R A ^a   Palomar Munoz A ^a   Talavera Rubio, M P ^a   Pilkington Woll, J P ^a   Gonzalez Garcia B ^a   Soriano Castrejon A ^a  

^a HOSPITAL GENERAL UNIVERSITARIO DE CIUDAD REAL   (Spain)

Author keywords

Endometrial cancer; Lymphoscintigraphy; Sentinel lymph node

Indexed keywords

ALBUMIN TC 99M; EOSIN; HEMATOXYLIN; METHYLENE BLUE; TRACER;

ADNEXECTOMY; ARTICLE; CANCER DIAGNOSIS; CANCER INVASION; CANCER PATIENT; CANCER STAGING; CELL INFILTRATION; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DRUG INJECTION VOLUME; ECHO PLANAR IMAGING; ENDOMETRIUM CANCER; ENDOMETRIUM CARCINOMA; ENDOMETRIUM SARCOMA; FEMALE; GAMMA RADIATION; GYNECOLOGIC SURGERY; HISTOPATHOLOGY; HUMAN; HYSTERECTOMY; PELVIS LYMPHADENECTOMY; PREDICTIVE VALUE; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE; SENTINEL LYMPH NODE BIOPSY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STAINING; UTERINE CERVIX;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, ENDOMETRIOID; ENDOMETRIAL NEOPLASMS; ENDOMETRIAL STROMAL TUMORS; FEMALE; HUMANS; LAPAROSCOPY; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MIDDLE AGED; PILOT PROJECTS; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; RADIOPHARMACEUTICALS; SENTINEL LYMPH NODE BIOPSY; TECHNETIUM TC 99M AGGREGATED ALBUMIN;

EID: 84865357075     PISSN: 2253654X     EISSN: 22538070     Source Type: Journal    
DOI: 10.1016/j.remn.2011.11.005     Document Type: Article

References (28)

1. Prat J., Gallardo A., Cuatrecasas M., Catasús L. Endometrial carcinoma: pathology and genetics. Pathology 2007, 39:72-87.
2. Chi D.S., Barakat R.R., Palayekar M.J., Levine D.A., Sonoda Y., Alektiar K., et al. The incidence of pelvic lymph node metastasis by FIGO staging for patients with adequately surgically staged endometrial adenocarcinoma of endometrioid histology. Int J Gynecol Cancer 2008, 18:269-273.
3. Abu-Rustum N.R., Gomez J.D., Alektiar K.M., Soslow R.A., Hensley M.L., Leitao M.M., et al. The incidence of isolated paraaortic nodal metastasis in surgically staged endometrial cancer patients with negative pelvic lymph nodes. Gynecol Oncol 2009, 115:236-238.
4. Mariani A., Keeney G.L., Aletti G., Webb M.J., Haddock M.G., Podratz K.C. Endometrial carcinoma: paraaortic dissemination. Gynecol Oncol 2004, 92:833-838.
5. Todo Y., Kato H., Kaneuchi M., Watari H., Takeda M., Sakuragi N. Survival effect of para-aortic lymphadenectomy in endometrial cancer (SEPAL study): a retrospective cohort analysis. Lancet 2010, 375:1165-1172.
6. Soliman P.T., Frumovitz M., Spannuth W., Greer M.J., Sharma S., Schmeler K.M., et al. Lymphadenectomy during endometrial cancer staging: Practice patterns among gynecologic oncologists. Gynecol Oncol 2010, 119:291-294.
7. Mariani A., Dowdy S.C., Cliby W.A., Gostout B.S., Jones M.B., Wilson T.O., et al. Prospective assessment of lymphatic dissemination in endometrial cancer: a paradigm shift in surgical staging. Gynecol Oncol 2008, 109:11-18.
8. May K., Bryant A., Dickinson H.O., Kehoe S., Morrison J. Lymphadenectomy for the management of endometrial cancer. Cochrane Database Syst Rev 2010, 1:CD007585.
9. Kehoe S.M., Miller D.S. The role of lymphadenectomy in endometrial cancer. Clin Obstet Gynecol 2011, 54:235-244.
10. Benedetti Panici P., Basile S., Maneschi F., Alberto Lissoni A., Signorelli M., Scambia G., et al. Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial. J Natl Cancer Inst 2008, 100:1707-1716.
11. Benedet J.L., Bender H., Jones H., Ngan H.Y., Pecorelli S. FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers. FIGO Committee on Gynecologic Oncology. Int J Gynaecol Obstet 2000, 70:209-262.
12. Colombo N., Preti E., Landoni F., Carinelli S., Colombo A., Marini C., et al. Endometrial cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2011, 22:vi35-vi39.
13. Vidal-Sicart S., Doménech B., Luján B., Pahisa J., Torné A., Martínez-Román S., et al. Ganglio centinela en cánceres ginecológicos. Nuestra experiencia. Rev Esp Med Nucl 2009, 28:221-228.
14. Abu-Rustum N.R., Khoury-Collado F., Pandit-Taskar N., Soslow R.A., Dao F., Sonoda Y., et al. Sentinel lymph node mapping for grade 1 endometrial cancer: is it the answer to the surgical staging dilemma?. Gynecol Oncol 2009, 113:163-169.
15. Mariani A., Dowdy S.C., Podratz K.C. New surgical staging of endometrial cancer: 20 years later. Int J Gynaecol Obstet 2009, 105:110-111.
16. Kitchener H., Swart A.M., Qian Q., Amos C., Parmar M.K. Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study. Lancet 2009, 373:125-136.
17. Blake P., Swart A.M., Orton J., Kitchener H., Whelan T., Lukka H., et al. Adjuvant external beam radiotherapy in the treatment of endometrial cancer (MRC ASTEC and NCIC CTG EN.5 randomised trials): pooled trial results, systematic review, and meta-analysis. Lancet 2009, 373:137-146. ASTEC/E.N.5 Study Group.
18. Bézu C., Coutant C., Ballester M., Feron J.G., Rouzier R., Uzan S., et al. Ultrastaging of lymph nodes in uterine cancers. J Exp Clin Cancer Res 2010, 29:5-13.
19. Yabushita H., Shimazu M., Yamada H., Sawaguchi K., Noguchi M., Nakanishi M., et al. Occult lymph node metastases detected by cytokeratin immunohistochemistry predict recurrence in node-negative endometrial cancer. Gynecol Oncol 2001, 80:139-144.
20. Ballester M., Dubernard G., Lécuru F., Heitz D., Mathevet P., Marret H., et al. Detection rate and diagnostic accuracy of sentinel-node biopsy in early stage endometrial cancer: a prospective multicentre study (SENTI-ENDO). Lancet Oncol 2011, 12:469-476.
21. Burke T.W., Levenback C., Tornos C., Morris M., Wharton J.T., Gershenson D.M. Intraabdominal lymphatic mapping to direct selective pelvic and paraaortic lymphadenectomy in women with high-risk endometrial cancer: results of a pilot study. Gynecol Oncol 1996, 62:169-173.
22. Oonk M.H., van de Nieuwenhof H.P., de Hullu J.A., van der Zee A.G. The role of sentinel node biopsy in gynecological cancer: a review. Curr Op Oncol 2009, 21:425-432.
23. Ballester M., Rouzier R., Coutant C., Kerrou K., Daraï E. Limits of lymphoscintigraphy for sentinel node biopsy in women with endometrial cancer. Gynecol Oncol 2009, 112:348-352.
24. Perrone A.M., Casadio P., Formelli G., Levorato M., Ghi T., Costa S., et al. Cervical and hysteroscopic injection for identification of sentinel lymph node in endometrial cancer. Gynecol Oncol 2008, 111:62-67.
25. Khoury-Collado F., Abu-Rustum N.R. Lymphatic mapping in endometrial cancer: literature review of current techniques and results. Int J Gynecol Cancer 2008, 18:1163-1168.
26. Delpech Y., Coutant C., Darai E., Barranger E. Sentinel lymph node evaluation in endometrial cancer and the importance of micrometastases. Surg Oncol 2008, 17:237-245.
27. Pandit-Taskar N., Gemignani M.L., Lyall A., Larson S.M., Barakat R.R., Abu Rustum N.R. Single photon emission computed tomography SPECT-TC improves sentinel node detection and localization in cervical and uterine malignancy. Gynecol Oncol 2010, 117:59-64.
28. Khoury-Collado F., Murray M.P., Hensley M.L., Sonoda Y., Alektiar K.M., Levine D.A., et al. Sentinel lymph node mapping for endometrial cancer improves the detection of metastatic disease to regional lymph nodes. Gynecol Oncol 2011, 122:251-254.